This effect on moesin levels may be protective in PDAC, as a previous study identified that moesin expression is low in pancreatic cancer, including PDAC, and that moesin knock-down increased migration, invasion, and metastasis [62]. This evidence concerns the gene MSN and familial pancreatic carcinoma.